Immunopathogenesis of delayed-type hypersensitivity
✍ Scribed by Kazuo Kobayashi; Kenji Kaneda; Tsuyoshi Kasama
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 86 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1059-910X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cell‐mediated immunity is defined as a beneficial host response characterized by an expanded population of specific T cells, which, in the presence of antigens, produce cytokines locally. The activation and recruitment of cells into an area of inflammation is a crucial step in the development of DTH responses. DTH is immunologically a process similar to cell‐mediated immunity, involving T cells and cytokines. CD4 T helper (Th) 1 cells, differentiated from naive Th cells by IL‐12 and IL‐18 produced from macrophages, play a regulatory role in the expression of DTH and activation of macrophages via interferon γ generated by Th1 and natural killer cells. Macrophages accumulate at the site of DTH and become activated through the CD4 Th1 cell‐cytokine‐macrophage axis. However, DTH leads to pathologic responses, such as granulomatous inflammation, calcification, caseation necrosis, and cavity formation. Granulomas usually form as a result of the persistence of a nondegradable product or as the result of DTH responses. DTH is also required for host defense against etiologic agents, such as Mycobacterium tuberculosis. The expression of cell‐mediated immunity/DTH is a double‐edged sword that may contribute to both clearance of the etiologic agent and tissue damage. Microsc. Res. Tech. 53:241–245, 2001. © 2001 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A previous study (__Eur. J. Immunol.__ 1977. __7__: 714) has shown that mice injected intravenously (i.v.) with 1 × 10^9^ sheep red blood cells (SRBC) produce cells which suppress delayed‐type hypersensitivity (DTH). These suppressor cells are Θ‐positive, antigen‐specific and act via a